+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Embolotherapy Market by Product Type (Balloons, Coils, Liquid Embolics), Application (Neurovascular Embolization, Peripheral Embolization, Prostate Artery Embolization), End User - Global Forecast 2025-2030- Product Image
Embolotherapy Market by Product Type (Balloons, Coils, Liquid Embolics), Application (Neurovascular Embolization, Peripheral Embolization, Prostate Artery Embolization), End User - Global Forecast 2025-2030- Product Image
Sale

Embolotherapy Market by Product Type (Balloons, Coils, Liquid Embolics), Application (Neurovascular Embolization, Peripheral Embolization, Prostate Artery Embolization), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829978
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The embolotherapy market is experiencing dynamic transformation as demand for minimally invasive vascular procedures accelerates and healthcare stakeholders seek smarter, value-based intervention options. This report distills current innovations, market forces, and competitive strategies driving sustained growth and opportunity for decision-makers considering investments in embolotherapy solutions.

Market Snapshot: Embolotherapy Market Size and Growth Trajectory

The embolotherapy market grew from USD 4.79 billion in 2024 to USD 5.22 billion in 2025. It is expected to continue expanding at a CAGR of 8.94%, reaching a projected value of USD 8.01 billion by 2030. Segment momentum is propelled by a blend of technological advances, broader clinical adoption, and expanding reimbursable applications. Both established and emerging markets are shaping the competitive landscape through investment in next-generation device platforms, specialized service models, and evolving clinical indications.

Scope & Segmentation of This Embolotherapy Market Report

This research provides in-depth analysis of the embolotherapy ecosystem, covering diverse segments, trends, and emerging opportunities across regions. Comprehensive segmentation includes:

  • Product Types: Balloons, Coils, Liquid Embolics, Particle Embolics, Plugs
  • Applications: Neurovascular Embolization (including Arteriovenous Malformation, Cerebral Aneurysm, Tumor Embolization), Peripheral Embolization (Peripheral Arterial and Venous), Prostate Artery Embolization, Transarterial Chemoembolization, Transarterial Radioembolization, Uterine Fibroid Embolization
  • End Users: Ambulatory Surgical Centers, Hospitals, Specialty Clinics (Oncology Centers, Vascular Centers)
  • Geographies: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; plus Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Main Companies Tracked: Boston Scientific Corporation, Terumo Corporation, Medtronic plc, Johnson & Johnson, Becton Dickinson and Company, Penumbra Inc., Merit Medical Systems Inc., Cook Medical LLC, MicroVention Inc., Asahi Intecc Co. Ltd.

This segmentation enables benchmarking of specific growth drivers, technology deployment, and evolving clinical pathways across distinct healthcare environments.

Key Takeaways: Strategic Insights for Decision-Makers

  • Growing clinical adoption of embolotherapy is closely linked with demand for minimally invasive procedures and shortened recovery times across hospital and ambulatory settings.
  • Advancements in catheter design, imaging integration, and biomaterial formulation are enhancing safety and targeting precision, which is fostering broader acceptance in new clinical specialties.
  • Strategic partnerships between device manufacturers, biotechnology firms, and research organizations are driving a pipeline of novel agents and combination therapies.
  • Health system emphasis on value-based care is catalyzing the development of embolics that combine therapeutic delivery with occlusion, improving both clinical outcomes and procedural efficiency.
  • The decentralization of high-complexity embolotherapy procedures is enabling specialty clinics and outpatient facilities to expand service offerings, thereby alleviating pressure on hospitals.
  • Competitive differentiation is increasingly achieved through a combination of innovative products and outcome-driven service models, including procedure support and advanced clinician training.

Tariff Impact: Navigating U.S. Policy Shifts

Newly anticipated United States tariffs for 2025 are influencing supply chain strategies for embolization devices, especially around sourcing of polymers, radiopaque materials, and key microcatheter components. Market participants are readjusting procurement, exploring regional manufacturing hubs, and creating partnerships to decrease tariff-related risks and stabilize cost structures. For health providers and payers, this context requires agile pricing models and enhanced scrutiny of cost-effectiveness.

Methodology & Data Sources

This report employs a dual-layered methodology, integrating extensive secondary analysis—including peer-reviewed literature, regulatory filings, and proprietary device approval databases—with primary research, such as expert interviews and Delphi panel validation. Quantitative projections include scenario analyses accounting for regulatory and market shifts, with all findings peer-reviewed for accuracy and relevance.

Why This Report Matters

  • Enables informed strategic planning by benchmarking technological advancements and adoption trends in embolotherapy across product, application, and regional lines.
  • Facilitates risk management and resilience strategies by capturing tariff impacts and evolving regulatory environments that directly affect procurement and pricing.
  • Supports identification of partnership, innovation, and service model opportunities to drive competitive advantage and sustained growth.

Conclusion

Embolotherapy continues to evolve, driven by technological integration, regional policy changes, and patient-centric care demands. Stakeholders equipped with thorough, forward-looking insights will be best positioned to capitalize on market shifts and emerging opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing utilization of radiopaque microspheres to enhance visualization during transarterial embolization procedures
5.2. Integration of image-guided robotic catheters for precise delivery in peripheral vascular embolization treatments
5.3. Expanding applications of biodegradable microspheres for temporary vascular occlusion in hemorrhage control
5.4. Shift toward personalized embolic formulations combining immunotherapy agents for hepatocellular carcinoma management
5.5. Advancements in dual-lumen balloon microcatheter systems to optimize chemoembolization efficacy in liver tumors
5.6. Growing approval and clinical adoption of liquid embolic polymers in arteriovenous malformation interventions
5.7. Increased focus on safety and efficacy through incorporation of biodegradable crosslinked hydrogel embolic materials
5.8. Emergence of combination embolotherapy with radioisotope-loaded microspheres for targeted liver cancer ablation
5.9. Development of next-generation bioresorbable embolic coils offering improved recanalization control in aneurysm repair
5.10. Adoption of artificial intelligence-driven treatment planning to optimize embolotherapy outcomes and reduce procedure time
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Embolotherapy Market, by Product Type
8.1. Introduction
8.2. Balloons
8.3. Coils
8.4. Liquid Embolics
8.5. Particle Embolics
8.6. Plugs
9. Embolotherapy Market, by Application
9.1. Introduction
9.2. Neurovascular Embolization
9.2.1. Arteriovenous Malformation
9.2.2. Cerebral Aneurysm
9.2.3. Tumor Embolization
9.3. Peripheral Embolization
9.3.1. Peripheral Arterial Embolization
9.3.2. Peripheral Venous Embolization
9.4. Prostate Artery Embolization
9.5. Transarterial Chemoembolization
9.6. Transarterial Radioembolization
9.7. Uterine Fibroid Embolization
10. Embolotherapy Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
10.4.1. Oncology Centers
10.4.2. Vascular Centers
11. Americas Embolotherapy Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Embolotherapy Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Embolotherapy Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Boston Scientific Corporation
14.3.2. Terumo Corporation
14.3.3. Medtronic plc
14.3.4. Johnson & Johnson
14.3.5. Becton, Dickinson and Company
14.3.6. Penumbra, Inc.
14.3.7. Merit Medical Systems, Inc.
14.3.8. Cook Medical LLC
14.3.9. MicroVention, Inc.
14.3.10. Asahi Intecc Co., Ltd.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. EMBOLOTHERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. EMBOLOTHERAPY MARKET: RESEARCHAI
FIGURE 22. EMBOLOTHERAPY MARKET: RESEARCHSTATISTICS
FIGURE 23. EMBOLOTHERAPY MARKET: RESEARCHCONTACTS
FIGURE 24. EMBOLOTHERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EMBOLOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BALLOONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BALLOONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TUMOR EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TUMOR EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VENOUS EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VENOUS EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL RADIOEMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL RADIOEMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. CANADA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 102. CANADA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 103. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. MEXICO EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 165. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 170. GERMANY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 171. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. GERMANY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. GERMANY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 182. FRANCE EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 183. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 184. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 185. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. FRANCE EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. FRANCE EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. ITALY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 206. ITALY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 207. ITALY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 208. ITALY EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 209. ITALY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ITALY EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ITALY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. ITALY EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 218. SPAIN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 219. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 220. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 221. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. SPAIN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 224. SPAIN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 266. DENMARK EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 267. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 268. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 269. DENMARK EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. DENMARK EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. DENMARK EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. DENMARK EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 285. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. QATAR EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 290. QATAR EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 291. QATAR EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 292. QATAR EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 293. QATAR EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. QATAR EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. QATAR EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. QATAR EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 302. FINLAND EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 303. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 304. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 305. FINLAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. FINLAND EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. FINLAND EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. FINLAND EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. EGYPT EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. EGYPT EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. EGYPT EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 338. EGYPT EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 339. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 340. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 341. EGYPT EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. EGYPT EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. EGYPT EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 344. EGYPT EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 345. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. TURKEY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 348. TURKEY EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 349. TURKEY EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 350. TURKEY EMBOLOTHERAPY MARKET SIZE, BY NE

Samples

Loading
LOADING...

Companies Mentioned

  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Becton, Dickinson and Company
  • Penumbra, Inc.
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • MicroVention, Inc.
  • Asahi Intecc Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.01 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Embolotherapy Global Market Report 2025 - Product Image

Embolotherapy Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Embolotherapy - Global Strategic Business Report - Product Image

Embolotherapy - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Embolotherapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Embolotherapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 109 Pages
  • Global
From
2025 Global Forecast for Embolotherapy Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Embolotherapy Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Embolotherapy Market

Embolotherapy is a minimally invasive medical procedure that involves the use of catheters to deliver therapeutic agents to a specific area of the body. The procedure is used to treat a variety of conditions, including vascular malformations, tumors, and arteriovenous malformations. Catheters are used to deliver embolic agents, such as coils, particles, and glue, to the target area. The catheters are inserted through a small incision in the skin and guided to the target area using imaging techniques such as X-ray, ultrasound, or computed tomography. The embolotherapy market is driven by the increasing prevalence of chronic diseases, the growing demand for minimally invasive procedures, and the availability of advanced catheter technologies. The market is further driven by the increasing adoption of embolotherapy in the treatment of various diseases, such as cancer, cardiovascular diseases, and neurological disorders. Some of the major companies in the embolotherapy market include Boston Scientific Corporation, Cook Medical, Medtronic, Terumo Corporation, Merit Medical Systems, Inc., and BTG plc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.